Earlier this week it was reported that Amazon after acquiring PillPack for $1 billion is making a deeper dive into the diabetes pool. Per a post on the BioPhramaDive web site;
“Amazon has begun marketing PillPack's at-home prescription drug delivery to Amazon Prime members via email and created a webpage about the service.”
“The marketing effort so far targets chronic conditions. The medications highlighted on the PillPack marketing include high blood pressure drugs amlodipine and lisinopril and diabetes drugs glipizide and metformin."
Amazon has also entered the diabetes toy business as well marketing their own line . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.